Infectious Diseases News

 

 

Today on Medscape

Top Stories from Across Medicine

Top Medical News from Across Medscape

  • Probiotics Promising for Mild to Moderate DepressionProbiotics have been shown to significantly reduce symptoms in patients with mild to moderate depression, offering hope of a safe and highly tolerable treatment for the disorder.
  • FDA Clears Long-Acting ADHD Drug MydayisMydayis (mixed salts of amphetamine) is formulated to last up to 16 hours and is approved for adults and children aged 13 years and older.
  • Texas Oncologist Runs for US CongressFrustrated and fearful about the future of healthcare in the United States, a medical oncologist and researcher from MD Anderson has decided to enter politics
  • FDA Panel Backs Liraglutide to Reduce CV Risk FactorsUPDATED // An FDA panel recommended liraglutide for the additional indication of reducing the risk for major adverse cardiovascular events in adults with type 2 diabetes and high cardiovascular risk.
  • Blood Test to Target Prostate Cancer TreatmentA new 3-in-1 blood test could revolutionise the treatment of prostate cancer, say scientists, and help pave the way for personalised patient treatment.

Perspective

Business of Medicine

  • The War Over MOC Heats Up In at least 17 states, doctors are battling the American Board of Medical Specialties, hospitals, and insurers in an effort to make maintenance of certification optional. Here's how it's going.
  • A Hospital Gets Sued for Keeping a Patient Alive   Hospital clinicians who don't follow a patient's advance healthcare directive are at risk of being sued.

Columnists

Advisory Board

 

Medscape Editor-in-Chief

  • Eric J. Topol, MD Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute; Senior Consultant, Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California; Editor-in-Chief, Medscape